The effect of topical diclofenac 3% and calcitriol 3 mg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial

Tjinta Brinkhuizen*, Kiki J. A. Frencken, Patricia Nelemans, Marlou L. S. Hoff, Nicole W. J. Kelleners-Smeets, Axel zur Hausen, Michiel P. J. van der Horst, Dorit Rennspiess, Veronique J. L. Winnepenninckx, Maurice A. M. van Steensel, Klara Mosterd

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

23 Citations (Web of Science)
Original languageEnglish
Pages (from-to)126-134
JournalJournal of the American Academy of Dermatology
Issue number1
Publication statusPublished - Jul 2016


  • basal cell carcinoma
  • calcitriol
  • diclofenac
  • noninvasive
  • nonsteroidal anti-inflammatory drugs
  • targeted therapy
  • topical
  • vitamin D

Cite this